Information for Health Professionals

ASCIA develops Clinical Updates, Action/Treatment Plans, Guides, Checklists, Position Papers/Statements, Guidelines and e-training courses for health professionals.  

Quick links for this page

Allergic Rhinitis

• ASCIA Clinical Update - Allergic Rhinitis
  
• ASCIA Treatment Plan - Allergic Rhinitis
  
• ASCIA Allergic Rhinitis e-training for health professionals
  
• ASCIA Allergic Rhinitis e-training for pharmacists 
• References - Allergic Rhinitis Currently being updated
• Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols 
  

Allergy Prevention and Infant Feeding 

• Overview - Infant feeding and allergy prevention
• ASCIA Position Statement - Packaged Foods for Infants that Contain Most of the Common Food Allergens New April 2021
• ASCIA Clinical Update Infant Feeding and Allergy Prevention
• ASCIA Guidelines - Infant feeding and allergy prevention 
• ASCIA Guide: Stepwise management of eczema (atopic dermatitis) management 
• ASCIA Information on how to introduce solid foods to babies for allergy prevention 
  
• ASCIA Guide for introduction of peanut to infants with severe eczema and/or food allergy 
• References - Allergy Prevention

Anaphylaxis

• ASCIA Guidelines - Acute management of anaphylaxis Updated June 2021
  
• ASCIA Guidelines - Acute management of anaphylaxis in pregnancy 
• ASCIA Guidelines - Adrenaline (epinephrine) autoinjector prescription 
• ASCIA Guidelines - Prevention of anaphylaxis in schools, pre-schools and childcare: 2015 update
• ASCIA Anaphylaxis Resources Overview   
• ASCIA Checklists - Anaphylaxis 
• ASCIA Event record for allergic reactions 
• ASCIA Checklist - Transitioning patients from paediatric to adult services 
• ASCIA Checklist - Travel for people with allergy, asthma and anaphylaxis 
• ASCIA Anaphylaxis e-training for health professionals 
  
• ASCIA Anaphylaxis e-training for pharmacists 
• References - Anaphylaxis New June 2021

Drug (Medication) Allergy

• Drug (Medication) Allergy Hub
• ASCIA Action Plan for Drug (Medication) Allergy Updated June 2021
• ASCIA Record for Drug (Medication) Allergy Updated June 2021
• ASCIA Drug (Medication) Allergy Terms New August 2020
• ASCIA Penicillin Allergy Guide for health professionals Updated August 2020
• ASCIA Consensus Statement - Penicillin Allergy Updated August 2020
• ASCIA Consensus Statement - Cephalosporin Allergy (available to Members only) New July 2021
• ASCIA Drug allergy pre-clinic information template (available to Members only)
• ASCIA Clinical Update - Antibiotic Allergy
• ASCIA Penicillin Allergy etraining for health professionals https://etraininghp.ascia.org.au/penicillin-allergy
• References - Drug (Medication) Allergy Currently being updated

Food Allergy

• ASCIA Position Paper - Oral Immunotherapy for Food Allergy New April 2021
• ASCIA Guide - Milk Substitutes in Cow’s Milk Allergy 
• ASCIA Dietary avoidance information sheets 
• ASCIA Information HP - Lupin Allergy
• ASCIA Food Allergy e-training for health professionals 
  
• ASCIA Food Allergy e-training for pharmacists 
  
• ASCIA Food Allergen Challenge Protocols (available to Members only)
• References - Food Allergy Currently being updated

Immunodeficiency

• Immunodeficiency Overview
  
• ASCIA Immunodeficiency Strategy for Australia and New Zealand New October 2020
• References - Immunodeficiency Updated October 2020
• References - Hereditary Angioedema (HAE) Updated October 2020
• ASCIA Webinar - HAE
  
• ASCIA Position Paper and Management Plan - Hereditary Angioedema (HAE) 
  
• ASCIA Clinical Update - Primary Immunodeficiencies (PID) 
  
• ASCIA Position Statement - Subcutaneous Immunoglobulin (SCIg) 
  
• ASCIA Guide – Setting up a Subcutaneous Immunoglobulin (SCIg) program in a hospital 
• ASCIA Guidelines for Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in Australia and New Zealand: A TAPID Consensus Guideline
• ASCIA Guidelines - Standardised IVIg Infusion Rates for IRT
  
• ASCIA SCIg Treatment Plan 
  
• ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy) 
  
• ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy 
  
• ASCIA ID Register How to access information (available to Members Only)

Immunisation

• ASCIA Guidelines - vaccination of the egg allergic individual 
• ASCIA COVID-19 vaccine information New March 2021

Insect Allergy      

• ASCIA Guide - Venom Immunotherapy, References and Consent Form 
• ASCIA Venom and Aeroallergen Immunotherapy templates (available to Members only)
• ASCIA Position Statement - Jack Jumper Ant Venom Immunotherapy
• ASCIA Information for HP - Jack Jumper Ant Allergy - a uniquely Australian problem
• ASCIA Treatment Plan – Subcutaneous Immunotherapy (SCIT) Updated May 2021
• Information about Venom Immunotherapy availability

Latex Allergy

• ASCIA Guidelines - Management of Latex-Allergic Individuals

Skin

• ASCIA Action Plan for Eczema
• ASCIA Guide: Stepwise management of eczema (atopic dermatitis) management 
• ASCIA Paediatric atopic dermatitis (eczema) e-training for health professionals
• ASCIA Position Paper and Guidelines: Chronic Spontaneous Urticaria (CSU)
• References - Chronic Spontaneous Urticaria (CSU)  Currently being updated

Tests

• Laboratory Investigation of Allergic Diseases New December 2020
• ASCIA Position Paper - Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments New March 2021
• References - Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments New March 2021
• ASCIA Skin Prick Testing (SPT) Guide for Health Professionals 
• ASCIA Food Allergen Challenge Protocols (available to Members only)
• ASCIA Guidelines - Anti-Intrinsic Factor Antibody Testing
• ASCIA Guidelines - Uncertainty of Measurement 

External Documents

• Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols
• Australian & New Zealand Anaesthetic Allergy Group (ANZAAG) - anaphylaxis management guidelines
• Australian Prescriber Anaphylaxis Wall Chart
• Australian Academy of Science - The science of immunisation
• APIIEG Consensus Recommendations for the Use of Immunoglobulin Replacement Therapy in Immune Deficiency 
• Guidelines for the Use of Infant Formulas to Treat Cows Milk Protein Allergy: an Australian Consensus Panel Opinion
• European Academy of Allergology and Clinical Immunology (EAACI) Testing for IgG4 against Foods is Not Recommended as a Diagnostic Tool 

For information about how ASCIA information is developed go to: www.allergy.org.au/about-ascia/website-information

Content updated July 2021